Advertisement

One-year efficacy of the RUDI technique for flow reduction in high-flow autologous brachial artery-based hemodialysis vascular access

One-year efficacy of the RUDI technique for flow reduction in high-flow autologous brachial artery-based hemodialysis vascular access

J Vasc Access 2015; 16(Suppl. 9): 96 - 101

Article Type: ORIGINAL ARTICLE

DOI:10.5301/jva.5000357

Authors

Roel H.D. Vaes, Magda van Loon, Selma M.M. Vaes, Philippe Cuypers, Jan H. Tordoir, Marc R. Scheltinga

Corresponding author

  • Roel H.D. Vaes
  • Department of Surgery
  • de Run 4600
  • 5500 MB Veldhoven, The Netherlands
  • r.vaes@mmc.nl

Abstract

Flow reduction is advised in hemodialysis (HD) patients with a high-flow (>2 L/min) arteriovenous fistula (AVF). The revision using distal inflow (RUDI) technique is based on the premise that access flow is attenuated once inflow is provided by a smaller caliber forearm artery. Aim of the study was to evaluate the efficacy of RUDI during a 1-year follow-up.

All HD patients undergoing a RUDI operation using a greater saphenous vein (GSV) or a basilic vein (BaV) interposition for a high-flow access (HFA, >2 L/min) during a 3.5-year time period were included. Serial access flow, percentage of freedom from recurrent high flow and complications were determined.

A total of 19 HFA patients were studied (11 males, age 55 ± 3 years). All AVFs were brachial artery based (brachiocephalic, n = 14; brachiobasilic, n = 5). RUDI immediately reduced access flow by almost 2 L/min (3,080 ± 200 to 1,170 ± 160 mL/min (p = 0.001)). Access flows at 1, 6 and 12 months were 1,150 ± 160, 1,460 ± 200 and 1,580 ± 260 mL/min, respectively. Postoperative complications included insufficient flow reduction (n = 1, BaV) and occlusion requiring revision (n = 1, GSV). Recurrent HFA occurred three times (n = 2 BaV, n = 1 GSV). Access flows were significantly (p<0.05) higher in the BaV group compared to the GSV group.

RUDI effectively reduces access flow in a brachial artery-based high-flow HD vascular access. A flow-reducing effect is sustained at 1-year follow-up in most patients. GSV is preferred as an interposition graft compared to a BaV.

Article History

Disclosures

Financial support: The manuscript did not receive any kind of financial support.
Conflict of interest: No conflict of interest.

This article is available as full text PDF.

  • If you are a Subscriber, please log in now.

  • Article price: Eur 36,00
  • You will be granted access to the article for 72 hours and you will be able to download any format (PDF or ePUB). The article will be available in your login area under "My PayPerView". You will need to register a new account (unless you already own an account with this journal), and you will be guided through our online shop. Online purchases are paid by Credit Card through PayPal.
  • If you are not a Subscriber you may:
  • Subscribe to this journal
  • Unlimited access to all our archives, 24 hour a day, every day of the week.

Authors

  • Vaes, Roel H.D. [PubMed] [Google Scholar] 1, * Corresponding Author (r.vaes@mmc.nl)
  • van Loon, Magda [PubMed] [Google Scholar] 2
  • Vaes, Selma M.M. [PubMed] [Google Scholar] 3
  • Cuypers, Philippe [PubMed] [Google Scholar] 4
  • Tordoir, Jan H. [PubMed] [Google Scholar] 2, 5
  • Scheltinga, Marc R. [PubMed] [Google Scholar] 1, 5

Affiliations

  • Department of Surgery, Máxima Medical Center, Veldhoven - The Netherlands
  • Department of Surgery, Maastricht University Medical Center, Maastricht - The Netherlands
  • Maastricht University, Maastricht - The Netherlands
  • Department of Surgery, Catharina Hospital, Eindhoven - The Netherlands
  • Carim Research School, Maastricht University Medical Center, Maastricht - The Netherlands

Article usage statistics

The blue line displays unique views in the time frame indicated.
The yellow line displays unique downloads.
Views and downloads are counted only once per session.

No supplementary material is available for this article.